A detailed history of Cinctive Capital Management LP transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Cinctive Capital Management LP holds 356,308 shares of WVE stock, worth $4.78 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
356,308
Previous 100,162 255.73%
Holding current value
$4.78 Million
Previous $499,000 485.37%
% of portfolio
0.17%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.12 - $9.01 $1.31 Million - $2.31 Million
256,146 Added 255.73%
356,308 $2.92 Million
Q2 2024

Aug 14, 2024

BUY
$4.38 - $6.48 $139,091 - $205,778
31,756 Added 46.42%
100,162 $499,000
Q1 2024

May 15, 2024

BUY
$3.54 - $6.84 $153,657 - $296,897
43,406 Added 173.62%
68,406 $422,000
Q4 2023

Feb 14, 2024

BUY
$4.16 - $6.87 $104,000 - $171,750
25,000 New
25,000 $126,000

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $1.16B
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Cinctive Capital Management LP Portfolio

Follow Cinctive Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cinctive Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Cinctive Capital Management LP with notifications on news.